TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

被引：0
|
作者：
Chen, Qingxiao [1 ]
He, Jingsong [1 ]
Guo, Xing [1 ]
Chen, Jing [1 ]
Yang, Li [1 ]
Lin, Xuanru [1 ]
Li, Yi [1 ]
Zhang, Enfan [1 ]
Yang, Yang [1 ]
Wu, Wenjun [1 ]
He, Donghua [1 ]
Huang, He [1 ]
Liu, Shizhou [2 ]
Cai, Zhen [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Loss of TET2 and TET3 in regulatory T cells unleashes effector function
    Xiaojing Yue
    Chan-Wang J. Lio
    Daniela Samaniego-Castruita
    Xiang Li
    Anjana Rao
    Nature Communications, 10
  • [42] Impact of Tet2 Deficiency, and of TET2 Mutations in Clonal Hematopoiesis, on Neutrophil/Granulocyte Immune Function
    Cook, Elina K.
    Luo, Michael
    Mewburn, Jeffrey
    Dunham-Snary, Kimberly J.
    Hindmarch, Charles
    Archer, Stephen L.
    Rauh, Michael J.
    BLOOD, 2021, 138
  • [43] The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
    Zhao, Huihui
    Zhu, Huayuan
    Huang, Jiayu
    Zhu, Yu
    Hong, Ming
    Zhu, Han
    Zhang, Jingjing
    Li, Shan
    Yang, Lijia
    Lian, Yun
    Wang, Shuai
    Mao, Jianping
    Chen, Yaoyu
    Li, Jianyong
    Qian, Sixuan
    LEUKEMIA RESEARCH, 2018, 66 : 1 - 7
  • [44] The Synergy of Vitamin C with Decitabine Activates TET2 in Leukemic Cells and Significantly Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia
    Zhao, Huihui
    Zhu Huayuan
    Yu, Zhu
    Li, Jianyong
    Qian, Sixuan
    BLOOD, 2017, 130
  • [45] In patients (pts) with acute myeloid leukemia (AML) a TET2 polymorphism is linked to TET2-mutation-associated clonal hematopoiesis (CH)
    Brauer, D.
    Grimm, J.
    Jentzsch, M.
    Bill, M.
    Goldmann, K.
    Schulz, J.
    Niederwieser, D.
    Platzbecker, U.
    Schwind, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 86 - 86
  • [46] Dysregulation of TET2 in hematologic malignancies
    Shigeru Chiba
    International Journal of Hematology, 2017, 105 : 17 - 22
  • [47] TET2, an “ambiguous” player in inflammation
    Ana María Espinosa-Oliva
    Miguel Angel Burguillos
    Neural Regeneration Research, 2020, 15 (08) : 1481 - 1482
  • [48] TET2 mutations in childhood leukemia
    Langemeijer, S. M. C.
    Jansen, J. H.
    Hooijer, J.
    van Hoogen, P.
    Stevens-Linders, E.
    Massop, M.
    Waanders, E.
    van Reijmersdal, S. V.
    Stevens-Kroef, M. J. P. L.
    Zwaan, C. M.
    van den Heuvel-Eibrink, M. M.
    Sonneveld, E.
    Hoogerbrugge, P. M.
    van Kessel, A. Geurts
    Kuiper, R. P.
    LEUKEMIA, 2011, 25 (01) : 189 - 192
  • [49] The Potential Equivalents of TET2 Mutations
    Pasca, Sergiu
    Jurj, Ancuta
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CANCERS, 2021, 13 (07)
  • [50] LOSS-OF-FUNCTION MUTATION IN TET2 IN ZEBRAFISH LEADS TO EARLY MDS LIKE PHENOTYPE
    Rajan, Vinothkumar
    Woodside, Rachel
    Prykhozhij, Sergey
    Berman, Jason
    EXPERIMENTAL HEMATOLOGY, 2018, 64 : S97 - S97
12345